Vicente García‐González

Author

Almirall (Spain)ORCID

Also Known As

V. García-González, Vicente García-González, Vicente García-González, Vicente García‐González

Publications

408

Citations

H-Index

Concepts

All Affiliations

Almirall (Spain)Universidad Pablo de Olavide Centro Andaluz de Biología del Desarrollo

About

Vicente García‐González is an author at Almirall (Spain) specializing in medicine, gene expression, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	128
2	Natural Sciences	2	2	100
3	Allergy	1	1	16
4	Biochemistry	1	1	79
5	Immunology	1	1	16

Vicente García‐González

Publications

227

Citations

H-Index

Page 1

	Year	Citations
Nitrogen Control of Atrazine Utilization in <i>Pseudomonas</i> sp. StrainADP Vicente García‐González, Fernando Govantes, Liz J. Shaw, Applied and Environmental Microbiology	2003	79
Regulation of the<i>Pseudomonas</i>sp. Strain ADP Cyanuric Acid Degradation Operon Vicente García‐González, Fernando Govantes, Odil Porrúa, Journal of Bacteriology Atzdef OperonTranscriptional RegulationBiosynthesisBiochemistryNatural Sciences	2004	79
Activation and repression of a σ<sup>N</sup>‐dependent promoter naturally lacking upstream activation sequences Odil Porrúa, Vicente García‐González, Eduardo Santero, Molecular Microbiology Atzdef OperonTranscriptional RegulationSystems BiologyMolecular RegulationNatural Sciences	2009	21
Keratinocytes activated by <scp>IL</scp>‐4/<scp>IL</scp>‐13 express <scp>IL‐2Rγ</scp> with consequences on epidermal barrier function Audrey Progneaux, C. Evrard, Valérie De Glas, Experimental Dermatology Immune RegulationImmunologyInnate ImmunityDermatologyImmune System	2023	16
Pharmacological characterization of CRTh2 antagonist LAS191859: Long receptor residence time translates into long-lasting in vivo efficacy Marta Calbet, Míriam Andrés, Clara Armengol, Pharmacological Research Molecular PharmacologyPharmacological CharacterizationMedicinePharmacologyCrth2 Antagonist Las191859	2016	12
Application of a phenotypic drug discovery strategy to identify biological and chemical starting points for inhibition of TSLP production in lung epithelial cells Adelina Orellana, Vicente García‐González, Rosa López-Gigosos, PLoS ONE	2018	10
Pharmacological characterization of a novel peptide inhibitor of the Keap1-Nrf2 protein-protein interaction Mònica Aparici, Mónica Bravo, Elena Calama, Biochemical Pharmacology	2022	10

Page 1